Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/173269
The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Germline protein truncating variants (PTVs) in the FANCM gene have been associated with a 2-4-fold increased breast cancer risk in case-control studies conducted in different European populations. However, the distribution and the frequency of FANCM PTVs in Europe have never been investigated. In the present study, we collected the data of 114 European female breast cancer cases with FANCM PTVs ascertained in 20 centers from 13 European countries. We identified 27 different FANCM PTVs. The p.Gln1701* PTV is the most common PTV in Northern Europe with a maximum frequency in Finland and a lower relative frequency in Southern Europe. On the contrary, p.Arg1931* seems to be the most common PTV in Southern Europe. We also showed that p.Arg658*, the third most common PTV, is more frequent in Central Europe, and p.Gln498Thrfs*7 is probably a founder variant from Lithuania. Of the 23 rare or unique FANCM PTVs, 15 have not been previously reported. We provide here the initial spectrum of FANCM PTVs in European breast cancer cases.
Matèries (anglès)
Citació
Citació
BRUNET, Joan, DARDER, Esther, VALLE DOMÍNGUEZ, Jesús del, LÁZARO GARCÍA, Conxi, ENIGMA Consortium, GENESIS Study Collaborators, SWE-BRCA Group. The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases. _Cancers_. 2020. Vol. 12, núm. 2. [consulta: 27 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/173269]